While we cannot gather in person this year, we look forward to enjoying a great virtual evening with you.
The evening will feature Dr. Francis Collins, Director of the National Institutes of Health. Researchers from Novartis, Roche, uniQure and Wave Life Sciences will provide an update on current clinical trials on Huntington's disease and what to expect in the coming year. We will hear about new cutting-edge research from the recipients of our Leslie Gehry Brenner Prize for Innovation in Science and the first Nancy S. Wexler Young Investigator Prize.
Join us to lift a glass from your location to toast the brilliant science that is changing the face of Huntington's disease!
The Hereditary Disease Foundation Gala & Symposium 2020 is open to all free of charge.
Keynote Speaker
Francis S. Collins, MD, PhD
Director
National Institutes of Health (NIH)
Awards
2020 Nancy S. Wexler Young Investigator Prize
Osama Al-Dalahmah, MD, DPhil, Columbia University Medical Center
2020 Leslie Gehry Brenner Prize for Innovation in Science
Ai Yamamoto, PhD, Associate Professor of Neurology, Columbia University
Clinical Trial Presenters
David Cooper, MD, PhD
Vice President of Clinical Development
uniQure
Paul Bolno, MD, MBA
President and Chief Executive Officer
Wave Life Sciences
Jang-Ho J. Cha, MD, PhD
Global Head, Translational Medicine, Neuroscience
Novartis Institutes for BioMedical Research
Sarah J. Tabrizi, FRCP, PhD, FMedSci
Director, University College London (UCL) HD Centre
Member of Strategic Steering Committee for the Roche HD Program